Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
9 June 2017
Question for written answer
to the Commission
Rule 130
Françoise Grossetête (PPE)

 Subject:  Industrial policy strategy: health sector

In its conclusions on a ‘future EU industrial policy strategy’ published on 29 May 2017, the Council called on the Commission to ‘provide a holistic EU industrial policy strategy for the future in time for the European Council meeting in spring 2018’.

Against that background, does the Commission intend to:

Include the European pharmaceutical sector, which plays an important role in generating jobs, growth, innovation and exports in Europe, in its future recommendations for industrial policy and to implement the action plan for the industry, as suggested by the Commission in its communication ‘A Stronger European Industry for Growth and Economic Recovery’, as soon as possible?
Relaunch a high-level dialogue, along the lines of the G10 in 2001-2002 and the Pharmaceutical Forum in 2005-2008, involving representatives of the Commission itself, the European Parliament and the Member States as well as key stakeholders from the health sector?

Original language of question: FR 
Last updated: 22 June 2017Legal notice